Pure Global

Mindfulness IN-home for Diabetes and Sleep Health - Trial NCT04160078

Access comprehensive clinical trial information for NCT04160078 through Pure Global AI's free database. This phase not specified trial is sponsored by Emory University and is currently Completed. The study focuses on Diabetes,Diabetes Mellitus, Type 2. Target enrollment is 18 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT04160078
Completed
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT04160078
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Mindfulness IN-home for Diabetes and Sleep Health
Adapting a Mindfulness Intervention to Improve Sleep and Reduce Diabetes Risk Among a Diverse Sample in Atlanta

Study Focus

Mindfulness-based stress reduction (MBSR) Intervention

Interventional

behavioral

Sponsor & Location

Emory University

Atlanta, United States of America

Timeline & Enrollment

N/A

Dec 18, 2019

Aug 29, 2021

18 participants

Primary Outcome

Change in average nightly sleep duration from baseline,Change in sleep timing from baseline,Change in sleep quality from baseline

Summary

The study investigates the effects of a mindfulness intervention on sleep and subsequent
 cardio-metabolic risk in an adult Atlanta population aged 18 and older.

ICD-10 Classifications

Type 2 diabetes mellitus
Type 2 diabetes mellitus with other specified complications
Type 2 diabetes mellitus with unspecified complications
Type 2 diabetes mellitus without complications
Type 2 diabetes mellitus with multiple complications

Data Source

ClinicalTrials.gov

NCT04160078

Non-Device Trial